BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14967145)

  • 41. The yeast 5'-3' exonuclease Rat1p functions during transcription elongation by RNA polymerase II.
    Jimeno-González S; Haaning LL; Malagon F; Jensen TH
    Mol Cell; 2010 Feb; 37(4):580-7. PubMed ID: 20188675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human capping enzyme promotes formation of transcriptional R loops in vitro.
    Kaneko S; Chu C; Shatkin AJ; Manley JL
    Proc Natl Acad Sci U S A; 2007 Nov; 104(45):17620-5. PubMed ID: 17978174
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell-based assays to detect inhibitors of fungal mRNA capping enzymes and characterization of sinefungin as a cap methyltransferase inhibitor.
    Chrebet GL; Wisniewski D; Perkins AL; Deng Q; Kurtz MB; Marcy A; Parent SA
    J Biomol Screen; 2005 Jun; 10(4):355-64. PubMed ID: 15964937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transition from initiation to promoter proximal pausing requires the CTD of RNA polymerase II.
    Lux C; Albiez H; Chapman RD; Heidinger M; Meininghaus M; Brack-Werner R; Lang A; Ziegler M; Cremer T; Eick D
    Nucleic Acids Res; 2005; 33(16):5139-44. PubMed ID: 16157863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A dual interface determines the recognition of RNA polymerase II by RNA capping enzyme.
    Suh MH; Meyer PA; Gu M; Ye P; Zhang M; Kaplan CD; Lima CD; Fu J
    J Biol Chem; 2010 Oct; 285(44):34027-38. PubMed ID: 20720002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence that the elongation factor TFIIS plays a role in transcription initiation at GAL1 in Saccharomyces cerevisiae.
    Prather DM; Larschan E; Winston F
    Mol Cell Biol; 2005 Apr; 25(7):2650-9. PubMed ID: 15767671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PTGS2 (prostaglandin endoperoxide synthase-2) expression in term human amnion in vivo involves rapid mRNA turnover, polymerase-II 5'-pausing, and glucocorticoid transrepression.
    Mitchell C; Johnson R; Bisits A; Hirst J; Zakar T
    Endocrinology; 2011 May; 152(5):2113-22. PubMed ID: 21385935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Yeast cap binding complex impedes recruitment of cleavage factor IA to weak termination sites.
    Wong CM; Qiu H; Hu C; Dong J; Hinnebusch AG
    Mol Cell Biol; 2007 Sep; 27(18):6520-31. PubMed ID: 17636014
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paip2 cooperates with Cbp80 at an active promoter and participates in RNA Polymerase II phosphorylation in Drosophila.
    Kachaev ZM; Lebedeva LA; Shaposhnikov AV; Moresco JJ; Yates JR; Schedl P; Shidlovskii YV
    FEBS Lett; 2019 May; 593(10):1102-1112. PubMed ID: 31001806
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trypanosome spliced leader RNA genes contain the first identified RNA polymerase II gene promoter in these organisms.
    Gilinger G; Bellofatto V
    Nucleic Acids Res; 2001 Apr; 29(7):1556-64. PubMed ID: 11266558
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mammalian capping enzyme complements mutant Saccharomyces cerevisiae lacking mRNA guanylyltransferase and selectively binds the elongating form of RNA polymerase II.
    Yue Z; Maldonado E; Pillutla R; Cho H; Reinberg D; Shatkin AJ
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):12898-903. PubMed ID: 9371772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RNA polymerase II-binding aptamers in human ACRO1 satellites disrupt transcription
    Boots JL; von Pelchrzim F; Weiss A; Zimmermann B; Friesacher T; Radtke M; Żywicki M; Chen D; Matylla-Kulińska K; Zagrovic B; Schroeder R
    Transcription; 2020 Oct; 11(5):217-229. PubMed ID: 32663063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tails of intrigue: phosphorylation of RNA polymerase II mediates histone methylation.
    Hampsey M; Reinberg D
    Cell; 2003 May; 113(4):429-32. PubMed ID: 12757703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RNA polymerase II pauses and associates with pre-mRNA processing factors at both ends of genes.
    Glover-Cutter K; Kim S; Espinosa J; Bentley DL
    Nat Struct Mol Biol; 2008 Jan; 15(1):71-8. PubMed ID: 18157150
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conditional inactivation of mRNA capping enzyme affects yeast pre-mRNA splicing in vivo.
    Schwer B; Shuman S
    RNA; 1996 Jun; 2(6):574-83. PubMed ID: 8718686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Wide-ranging and unexpected consequences of altered Pol II catalytic activity in vivo.
    Malik I; Qiu C; Snavely T; Kaplan CD
    Nucleic Acids Res; 2017 May; 45(8):4431-4451. PubMed ID: 28119420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of a eukaryotic gene by GTP-dependent start site selection and transcription attenuation.
    Kuehner JN; Brow DA
    Mol Cell; 2008 Jul; 31(2):201-11. PubMed ID: 18657503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure-function analysis of the mRNA cap methyltransferase of Saccharomyces cerevisiae.
    Wang SP; Shuman S
    J Biol Chem; 1997 Jun; 272(23):14683-9. PubMed ID: 9169431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional interactions of RNA-capping enzyme with factors that positively and negatively regulate promoter escape by RNA polymerase II.
    Mandal SS; Chu C; Wada T; Handa H; Shatkin AJ; Reinberg D
    Proc Natl Acad Sci U S A; 2004 May; 101(20):7572-7. PubMed ID: 15136722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Promoter clearance by RNA polymerase II.
    Luse DS
    Biochim Biophys Acta; 2013 Jan; 1829(1):63-8. PubMed ID: 22982364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.